42 results
8-K
EX-99.1
RPHM
Reneo Pharmaceuticals Inc
13 Nov 23
Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results
4:00pm
, and droopy eyelids among others. The prognosis for these disorders ranges in severity from progressive weakness to death.
About Mavodelpar
Mavodelpar
8-K
EX-99.1
RPHM
Reneo Pharmaceuticals Inc
10 Aug 23
Reneo Pharmaceuticals Reports Second Quarter 2023 Financial Results
4:01pm
in severity from progressive weakness to death.
Forward-Looking Statements
Statements contained in this press release regarding matters
8-K
EX-99.1
RPHM
Reneo Pharmaceuticals Inc
11 May 23
Reneo Pharmaceuticals Reports First Quarter 2023 Financial Results
4:07pm
. The prognosis for these disorders ranges in severity from progressive weakness to death.
Forward-Looking Statements
Statements contained in this press
8-K
EX-1.1
6w6q0cc
5 May 23
Reneo Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:33pm
8-K
EX-99.1
w2jjl2x
3 May 23
Results of Operations and Financial Condition
4:02pm
8-K
EX-99.1
0imonplgf982
8 Nov 22
Reneo Pharmaceuticals Reports Third Quarter 2022 Financial Results
4:16pm
8-K
EX-99.1
erm533q082
9 Aug 22
Reneo Pharmaceuticals Reports Second Quarter 2022 Financial Results
12:00am
8-K
EX-99.1
f0hw smh5ienh7dv
10 May 22
Reneo Pharmaceuticals Reports First Quarter 2022 Financial Results
4:09pm
DEF 14A
rx81nj 5b4jmz
22 Apr 22
Definitive proxy
4:05pm
10-K
EX-10.11
ycc 1k4om0
23 Mar 22
Annual report
4:38pm
10-K
u7j 806e4lz1
23 Mar 22
Annual report
4:38pm
8-K
EX-99.1
jv5wtco05how9582i5ew
23 Mar 22
Reneo Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
4:29pm
8-K
EX-99.1
prinupng75 eci21
12 Nov 21
Reneo Pharmaceuticals Reports Third Quarter 2021 Financial Results
9:00am